A Case of Pulmonary Cryptococcosis in a Patient with Psoriatic Arthritis Treated with Adalimumab.
10.4078/jrd.2011.18.3.216
- Author:
Su Nam LEE
1
;
Jun Ki MIN
;
Joon HUR
;
Dong Hwi KIM
;
Yong Hyun KIM
;
Soon Seog KWON
;
Heejeong LEE
Author Information
1. Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic Univercity of Korea, Seoul, Korea. rmin6403@hanmail.net
- Publication Type:Case Report
- Keywords:
Psoriatic arthritis;
Pulmonary cryptococcus;
Adalimumab
- MeSH:
Antibodies, Monoclonal, Humanized;
Arthritis, Psoriatic;
Cryptococcosis;
Fungi;
Humans;
Tuberculosis;
Tumor Necrosis Factor-alpha;
Adalimumab
- From:Journal of Rheumatic Diseases
2011;18(3):216-219
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Psoriatic arthritis is an immune-mediated chronic inflammatory disease triggered and maintained by inflammatory mediators, including tumor necrosis factor-alpha. Although TNF-alpha antagonist is effective for the treatment of psoriatic arthritis, infections caused by tuberculosis or fungus have emerged as significant complications of therapy. We report a case of pulmonary cryptococcosis in a patient with psoriatic arthritis treated with adalimumab.
